Form 8-K - Current report:
SEC Accession No. 0000950170-24-122784
Filing Date
2024-11-07
Accepted
2024-11-07 07:10:27
Documents
12
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K upb-20241107.htm   iXBRL 8-K 39467
2 EX-99.1 upb-ex99_1.htm EX-99.1 186697
  Complete submission text file 0000950170-24-122784.txt   359785

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT upb-20241107.xsd EX-101.SCH 26961
14 EXTRACTED XBRL INSTANCE DOCUMENT upb-20241107_htm.xml XML 5106
Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Filer) CIK: 0002022626 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42366 | Film No.: 241433127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)